Regulation of p53 in response to DNA damage

Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.

[1]  C. Prives Signaling to p53 Breaking the MDM2–p53 Circuit , 1998, Cell.

[2]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[3]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[4]  S. Jackson,et al.  DNA repair: The Nijmegen breakage syndrome protein , 1998, Current Biology.

[5]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[6]  M. Leppert,et al.  Localization of an ataxia-telangiectasia gene to chromosome 11q22–23 , 1988, Nature.

[7]  J B Lawrence,et al.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.

[8]  T. Kouzarides Histone acetylases and deacetylases in cell proliferation. , 1999, Current opinion in genetics & development.

[9]  D. Meek,et al.  p53 Is Phosphorylated in Vitro and in Vivo by an Ultraviolet Radiation-induced Protein Kinase Characteristic of the c-Jun Kinase, JNK1 (*) , 1995, The Journal of Biological Chemistry.

[10]  Hirofumi Tanaka,et al.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 , 1997, FEBS letters.

[11]  P. Herrlich,et al.  DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation , 1999, Oncogene.

[12]  A. Levine,et al.  The mdm-2 gene is induced in response to UV light in a p53-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[14]  D. Livingston,et al.  Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.

[15]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[16]  John R. Yates,et al.  Tra1p Is a Component of the Yeast Ada·Spt Transcriptional Regulatory Complexes* , 1998, The Journal of Biological Chemistry.

[17]  P. Friedman,et al.  Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[19]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[20]  J R Yates,et al.  The ATM-related cofactor Tra1 is a component of the purified SAGA complex. , 1998, Molecular cell.

[21]  L. Donehower,et al.  p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. , 1996, Genes & development.

[22]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[23]  K. Gardner,et al.  Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.

[24]  B. Vogelstein,et al.  Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Schreiber,et al.  cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Carr,et al.  Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Hupp,et al.  DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site , 1998, Oncogene.

[28]  S. Jackson,et al.  The DNA-dependent protein kinase , 1999 .

[29]  A. Deisseroth,et al.  Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function. , 1994, Cancer research.

[30]  C. Anderson,et al.  Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen , 1990, Molecular and cellular biology.

[31]  C. Prives,et al.  Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases , 1995, Nature.

[32]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[33]  M. Kastan,et al.  The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. , 1996, The American journal of pathology.

[34]  D. Lane,et al.  Allosteric activation of latent p53 tetramers , 1994, Current Biology.

[35]  G. Wahl,et al.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.

[36]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[37]  P. Howley,et al.  Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation , 1997, Molecular and cellular biology.

[38]  S. Benchimol,et al.  The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. , 1993, The EMBO journal.

[39]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[40]  D. George,et al.  Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. , 1991, The EMBO journal.

[41]  A. Carr,et al.  The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. , 1996, Genes & development.

[42]  K. Sakaguchi,et al.  Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.

[43]  Richard A. Ashmun,et al.  Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.

[44]  W. Jongmans,et al.  Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation , 1997, Molecular and cellular biology.

[45]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[46]  A. Fornace,et al.  The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. , 1994, Cancer research.

[47]  C. Prives,et al.  Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus , 1995, Cell.

[48]  T. Halazonetis,et al.  Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Lane,et al.  Small peptides activate the latent sequence-specific DNA binding function of p53 , 1995, Cell.

[50]  A. Jochemsen,et al.  Adenovirus E1A proteins inhibit activation of transcription by p53 , 1996, Molecular and cellular biology.

[51]  A. Giaccia,et al.  The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Halazonetis,et al.  Wild‐type p53 adopts a ‘mutant’‐like conformation when bound to DNA. , 1993, The EMBO journal.

[53]  Matthias Platzer,et al.  Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome , 1998, Cell.

[54]  M. Nussenzweig,et al.  Requirement for Ku80 in growth and immunoglobulin V(D)J recombination , 1996, Nature.

[55]  Xin Lu,et al.  Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? , 1993, Cell.

[56]  M. Grunstein Histone acetylation in chromatin structure and transcription , 1997, Nature.

[57]  A. Levine,et al.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.

[58]  F. Kashanchi,et al.  Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.

[59]  V. Yamazaki,et al.  Characterization of cell cycle checkpoint responses after ionizing radiation in Nijmegen breakage syndrome cells. , 1998, Cancer research.

[60]  S. Elledge,et al.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.

[61]  X. Chen,et al.  p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner , 1997, Molecular and cellular biology.

[62]  T. Unger,et al.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 , 1999, The EMBO journal.

[63]  M. Cole,et al.  The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.

[64]  W. Deppert,et al.  Negative feedback regulation of wild‐type p53 biosynthesis. , 1995 .

[65]  M. Kubbutat,et al.  Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.

[66]  S. Benchimol,et al.  Participation of the human p53 3′UTR in translational repression and activation following γ‐irradiation , 1997, The EMBO journal.

[67]  E. Stavridi,et al.  ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins , 1998, Nature Genetics.

[68]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[69]  M. Hoekstra Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family. , 1997, Current opinion in genetics & development.

[70]  H. Piwnica-Worms,et al.  A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Benchimol,et al.  Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells , 1999, Oncogene.

[72]  T. Unger,et al.  p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. , 1992, The EMBO journal.

[73]  S. Berger,et al.  p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.

[74]  I. Takenaka,et al.  Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases (*) , 1995, The Journal of Biological Chemistry.

[75]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[76]  M. Gatei,et al.  Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells , 1999, Oncogene.

[77]  Derrick E. Rancourt,et al.  DNA-dependent protein kinase acts upstream of p53 in response to DNA damage , 1998, Nature.

[78]  S. Jackson,et al.  The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.

[79]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[80]  S. Schreiber,et al.  Overexpression of a kinase‐inactive ATR protein causes sensitivity to DNA‐damaging agents and defects in cell cycle checkpoints , 1998, The EMBO journal.

[81]  D. Livingston,et al.  Association of p300 and CBP with simian virus 40 large T antigen , 1996, Molecular and cellular biology.

[82]  W Eckhart,et al.  Phosphorylation sites in the amino-terminal region of mouse p53. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[83]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[84]  A. Levine,et al.  Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[85]  A. Levine,et al.  Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6 , 1998, Molecular and Cellular Biology.

[86]  K. Muegge,et al.  p53-dependent apoptosis and transcription of p21waf/cip1/sdi1 in SCID mice following gamma-irradiation. , 1997, Biochimie.

[87]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[88]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[89]  W. Maltzman,et al.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.

[90]  B. Groner,et al.  Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain , 1997, Nature Medicine.

[91]  J. Danska,et al.  V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. , 1996, Genes & development.

[92]  Y. Shiloh,et al.  ATM: from gene to function. , 1998, Human molecular genetics.

[93]  D. Lane,et al.  p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding , 1997, Oncogene.

[94]  Wei Gu,et al.  Synergistic activation of transcription by CBP and p53 , 1997, Nature.

[95]  P. Howley,et al.  In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.

[96]  G. Wahl,et al.  Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[97]  Y Taya,et al.  DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization , 1999, The EMBO journal.

[98]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[99]  C. Anderson,et al.  DNA damage and the DNA-activated protein kinase. , 1993, Trends in biochemical sciences.

[100]  F. Alt,et al.  Growth retardation and leaky SCID phenotype of Ku70-deficient mice. , 1997, Immunity.

[101]  G. Chu,et al.  DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. , 1997, Cancer research.

[102]  V. Adler,et al.  Mdm2 association with p53 targets its ubiquitination , 1998, Oncogene.

[103]  Yoichi Taya,et al.  ATM associates with and phosphorylates p53: mapping the region of interaction , 1999, Nature Genetics.

[104]  Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation , 1998 .

[105]  Michael Wolfe,et al.  Parallelizing compilers , 1996, CSUR.

[106]  A. Blasina,et al.  A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase , 1999, Current Biology.

[107]  D. Lane,et al.  Regulation of the specific DNA binding function of p53 , 1992, Cell.

[108]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[109]  John R Yates,et al.  The hMre11/hRad50 Protein Complex and Nijmegen Breakage Syndrome: Linkage of Double-Strand Break Repair to the Cellular DNA Damage Response , 1998, Cell.

[110]  J. Qin,et al.  The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. , 1998, Molecular cell.

[111]  T. Jacks,et al.  Mutations in the p53 and SCID genes cooperate in tumorigenesis. , 1996, Genes & development.

[112]  K. Chrzanowska,et al.  Radiation induction of p53 in cells from Nijmegen breakage syndrome is defective but not similar to ataxia-telangiectasia. , 1998, Biochemical and biophysical research communications.

[113]  A. Levine,et al.  Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[114]  A. Carr,et al.  The Schizosaccharomyces pombe rad3 checkpoint gene. , 1996, The EMBO journal.

[115]  Yusuke Nakamura,et al.  Positional cloning of the gene for Nijmegen breakage syndrome , 1998, Nature Genetics.

[116]  K. Vousden,et al.  Transcriptional activation by p53 correlates with suppression of growth but not transformation , 1994, Cell.

[117]  D. Grunwald,et al.  Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[118]  D. Meek,et al.  Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation. , 1996, Nucleic acids research.

[119]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[120]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[121]  M. Oren,et al.  mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.

[122]  A. Levine,et al.  p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches , 1995, Cell.